Positron Opens Pharmaceutical Facility in Indiana
08/10/2010
"While the company's plan is to focus on small batch, radioactive PET products, the facility will also be utilized to support current and future Positron equipment, as well as, expand into new markets," said John Zehner, Positron COO.
The approximately 10,000-square-foot facility has room for the company to expand, and includes a clean room and laboratory to produce pharmaceuticals for industrial and medical applications. All products made at the Indiana facility will meet or exceed Food and Drug Administration (FDA) requirements.
Project Announcements
Finland-Based ADMARES Plans Waycross, Georgia, U.S. Manufacturing Plant
06/01/2023
Toyota Plans Georgetown, Kentucky, Electric Vehicle Operations
06/01/2023
Ranger Design Establishes North Charleston, South Carolina, Operations
05/31/2023
Austrian-Based Kronospan Expands Oxford, Alabama, Operations
05/30/2023
TiiCKER Expands Grand Rapids, Michigan, Operations
05/30/2023
Hanon Systems Establishes Bulloch County, Georgia, Operations
05/26/2023
Most Read
-
Is a Flurry of Fads Shaping Economic Development Policy?
Q2 2023
-
37th Annual Corporate Survey: Economic Pressures Exerting Greatest Effect on Decision-Makers
Q1 2023
-
Nearshoring — North America’s Next Factory
Q2 2023
-
Front Line: Water Supply Increasingly Affecting Location Decisions
Q2 2023
-
First Person: Labor Crunch in the Construction Industry
Q2 2023
-
Life Science Conversions in Real Estate
Q2 2023
-
19th Annual Consultants Survey: Clients Challenged by Tight Labor Market, Energy Availability
Q1 2023